Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

New class of potent anti-cancer compounds discovered

New class of potent anti-cancer compounds discovered

Zalutumumab significanly prolongs progression-free survival in patients with incurable head and neck cancer

Zalutumumab significanly prolongs progression-free survival in patients with incurable head and neck cancer

Advanced breast cancer drug eribulin shows promise in phase-III trial

Advanced breast cancer drug eribulin shows promise in phase-III trial

Medical oncology recognized at EU level to allow free movement of doctors

Medical oncology recognized at EU level to allow free movement of doctors

Valproic acid and rapamycin show potential anti tumour effect

Valproic acid and rapamycin show potential anti tumour effect

Population-based breast cancer screening not necessarily best for poorer countries

Population-based breast cancer screening not necessarily best for poorer countries

EMCTO 2011: Erlotinib as effective as chemotherapy, with fewer side-effects, in patients whose disease progressed after first-line treatment

EMCTO 2011: Erlotinib as effective as chemotherapy, with fewer side-effects, in patients whose disease progressed...

EMCTO 2011: Radio-guided surgery a safe and simple way to remove potentially cancerous nodules in the lung

EMCTO 2011: Radio-guided surgery a safe and simple way to remove potentially cancerous nodules in the lung

EMCTO 2011: Oncogene AEG-1 strongly predicts response to erlotinib treatment in EGFR-mutant lung cancer

EMCTO 2011: Oncogene AEG-1 strongly predicts response to erlotinib treatment in EGFR-mutant lung cancer

EMCTO 2011: Quick, easy test identifies aggressive type of lung cancer in never-smokers

EMCTO 2011: Quick, easy test identifies aggressive type of lung cancer in never-smokers

More from ecancer